Clinical Trial Details
| Trial ID: | L2931 |
| Source ID: | NCT00258804 |
| Associated Drug: | Insulin Glargine |
| Title: | Insulin Glargine During and After the Period of Fasting in Ramadan |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes Mellitus, Type 2 |
| Interventions: | DRUG: Insulin glargine |
| Outcome Measures: | Primary: Hypoglycaemic events (severe, symptomatic, asymptomatic, nocturnal) before, during and after Ramadan|Glycemic control before, during and after Ramadan in terms of HbA1c, FBG, 8-point blood glucose profile|All other adverse events before, during and after Ramadan|Patient satisfaction before, during and after Ramadan. | |
| Sponsor/Collaborators: | Sponsor: Sanofi |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 450 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2005-05 |
| Completion Date: | 2006-02 |
| Results First Posted: | |
| Last Update Posted: | 2011-06-08 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT00258804 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|